Fleebs-Logo
Details werden geladen...

Chevron reports positive results from Nargis-2 well in Mediterranean – Dailynewsegypt

The Ministry of Petroleum and Mineral Resources and global energy company Chevron have announced positive results from drilling the Nargis-2 natural gas well in the Mediterranean Sea. Drilling bega…

Ähnliche Seiten

https://www.dailynewsegypt.com/2026/10/20/egypt-targets-regional-gas-integration-and-reveals-6-1-bn-debt-clearance-at-mediterranean-offshore-conference/

Egypt targets regional gas integration and reveals $6.1 bn debt clearance at Mediterranean Offshore Conference – Dailynewsegypt

https://www.dailynewsegypt.com/2026/10/20/egypt-targets-regional-gas-integration-and-reveals-6-1-bn-debt-clearance-at-mediterranean-offshore-conference/
https://www.finanzen.at/nachrichten/aktien/cosmo-reports-positive-phase-2-results-for-rifamycin-gel-in-ulcerative-colitis-1036637879

Cosmo Reports Positive Phase 2 Results For Rifamycin Gel In Ulcerative Colitis | 19.10.26 | finanzen.at

https://www.finanzen.at/nachrichten/aktien/cosmo-reports-positive-phase-2-results-for-rifamycin-gel-in-ulcerative-colitis-1036637879
https://www.dailynewsegypt.com/2026/10/05/egypts-egas-chevron-sign-88m-gas-and-oil-exploration-deal-for-mediterranean-lotus-block/

Egypt’s EGAS, Chevron sign $88m gas and oil exploration deal for Mediterranean Lotus block – Dailynewsegypt

https://www.dailynewsegypt.com/2026/10/05/egypts-egas-chevron-sign-88m-gas-and-oil-exploration-deal-for-mediterranean-lotus-block/
https://www.finanzen.ch/nachrichten/aktien/galderma-reports-positive-clinical-results-for-enhanced-alastin-eye-complex-1036665781

Galderma Reports Positive Clinical Results For Enhanced ALASTIN Eye Complex | 26.10.26 | finanzen.ch

https://www.finanzen.ch/nachrichten/aktien/galderma-reports-positive-clinical-results-for-enhanced-alastin-eye-complex-1036665781
https://www.finanzen.ch/nachrichten/aktien/mirum-reports-positive-atebrioz-results-in-younger-children-with-fop-1036665658

Mirum Reports Positive ATEBRIOZ Results In Younger Children With FOP | 26.10.26 | finanzen.ch

https://www.finanzen.ch/nachrichten/aktien/mirum-reports-positive-atebrioz-results-in-younger-children-with-fop-1036665658
https://www.finanzen.ch/nachrichten/aktien/lilly-reports-olomorasib-results-eyes-first-phase-3-data-in-h1-2027-1036665049

Lilly Reports Olomorasib Results, Eyes First Phase 3 Data In H1 2027 | 26.10.26 | finanzen.ch

https://www.finanzen.ch/nachrichten/aktien/lilly-reports-olomorasib-results-eyes-first-phase-3-data-in-h1-2027-1036665049